PHARMACEUTICAL COMPOSITION FOR TREATING CANCER BY CONJUNCTIVE THERAPY WITH A 2(-HALOMETHYLIDENE DERIVATIVE AND A S-PHASE OR M-PHASE SPECIFIC ANTINEOPLASTIC AGENT

摘要

The present invention relates to a method of treating a patient suffering from a neoplastic disease state comprising administering to said patient an effective antineoplastic amount of a 2'-halomethylidene derivative in conjunctive therapy with an effective antineoplastic amount of a S phase or M-phase specific agent.